Table 1.
Clinic data of recipients with graft-vs-host disease
| Case | Age (yr)/sex | Etiology | HCC criteria | MELD score | Onset day | Presenting symptoms | Changes in PLT count | Changes in WBC count |
| 1 | 48/M | HCC/LC/HBV | UCSF | 28 | POD 23 | Fever, rash, diarrhea, BMS, gastrointestinal bleeding | 111 × 109/L to 12 × 109/L | 8.69 × 109/L to 0.28 × 109/L |
| 2 | 43/M | HCC/LC/HBV | Milan | 21 | POD 21 | Fever, rash, diarrhea, BMS, gastrointestinal bleeding | 124 × 109/L to 45 × 109/L | 7.59 × 109/L to 0.11 × 109 /L |
| 3 | 55/M | HCC/LC/HBV | Milan | 23 | POD 20 | Fever, rash, diarrhea, BMS, gastrointestinal bleeding | 273 × 109/L to 18 × 109/L | 4.39 × 109/L to 0.03 × 109/L |
| 4 | 56/F | LC/HBV | - | 27 | POD 21 | Fever, rash, diarrhea, BMS, gastrointestinal bleeding | 150 × 109/L to 1 × 109/L | 5.12 × 109/L to 0.16 × 109/L |
M: Male; F: Female; HCC: Hepatocellular carcinoma; LC: Liver cirrhosis; HBV: Hepatitis B virus; UCSF: University of California, San Francisco criteria for liver transplantation; BMS: Bone marrow suppression; POD: Post-operation day; MELD: Model for End-Stage Liver Disease; PLT: Platelet; WBC: White blood cell. Normal value for PLT is (100-300) × 109/L; Normal value for WBC is (4-10) × 109/L.